The maintaining musculoskeletal health (MAmMOTH) study: protocol for a randomised trial of cognitive behavioural therapy versus usual care for the prevention of chronic widespread pain
The maintaining musculoskeletal health (MAmMOTH) study: protocol for a randomised trial of cognitive behavioural therapy versus usual care for the prevention of chronic widespread pain
Background: cognitive behavioural therapy (CBT) has been shown to improve outcomes for patients with fibromyalgia, and its cardinal feature chronic widespread pain (CWP). Prediction models have now been developed which identify groups who are at high-risk of developing CWP. It would be beneficial to be able to prevent the development of CWP in these people because of the high cost of symptoms and because once established they are difficult to manage. We will test the hypothesis that among patients who are identified as at high-risk, a short course of telephone-delivered CBT (tCBT) reduces the onset of CWP. We will further determine the cost-effectiveness of such a preventative intervention.
Methods: the study will be a two-arm randomised trial testing a course of tCBT against usual care for prevention of CWP. Eligible participants will be identified from a screening questionnaire sent to patients registered at general practices within three Scottish health boards. Those returning questionnaires indicating they have visited their doctor for regional pain in the last 6 months, and who have two of, sleep problems, maladaptive behaviour response to illness, or high number of somatic symptoms, will be invited to participate. After giving consent, participants will be randomly allocated to either tCBT or usual care. We aim to recruit 473 participants to each treatment arm. Participants in the tCBT group will have an initial assessment with a CBT therapist by telephone, then 6 weekly sessions, and booster sessions 3 and 6 months after treatment start. Those in the usual care group will receive no additional intervention. Follow-up questionnaires measuring the same items as the screening survey questionnaire will be sent 3, 12 and 24 months after start of treatment. The main outcome will be CWP at the 12 month questionnaire.
Discussion: this will be the first trial of an intervention aimed at preventing fibromyalgia or CWP. The results of the study will help to inform future treatments for the prevention of chronic pain, and aetiological models of its development.
Trial registration: ClinicalTrials.gov ID: NCT02668003URL: Please check that the following URLs are working. If not, please provide alternatives: NCT02668003Alternative is: https://www.clinicaltrials.gov/ct2/show/NCT02668003>. Date registered: 28-Jan-2016.
Macfarlane, Gary J.
332acabb-a9cf-4434-b375-c8dd3a659e9f
Beasley, Marcus
a40436eb-bd78-4d2a-889f-6b99d7755091
Prescott, Gordon
8d0985a4-5168-4279-9d5f-bbecf4b8b9d7
McNamee, Paul
77afd18f-a2f7-4165-8b26-de11124102ee
Keeley, Philip
15f0a3af-8d97-4efa-90a2-c53f5d56eeb3
Artus, Majid
cdfc2742-beef-4849-8d44-319bd6338da1
McBeth, John
98012716-66ba-480b-9e43-ac53b51dce61
Hannaford, Philip
b3b54676-6dd4-4367-bc2d-684ab6ac9709
Jones, Gareth T.
d3a29bae-af6f-4ea8-aebb-1004c31112a0
Basu, Neil
a7cb81d4-9e2c-4ce4-a6f4-3b2a6d5808de
Norrie, John
d648d104-39a0-481f-af0f-9a7209d50fb5
Lovell, Karina
32288970-1a2d-4abd-acd6-00e16e22ca1d
26 April 2016
Macfarlane, Gary J.
332acabb-a9cf-4434-b375-c8dd3a659e9f
Beasley, Marcus
a40436eb-bd78-4d2a-889f-6b99d7755091
Prescott, Gordon
8d0985a4-5168-4279-9d5f-bbecf4b8b9d7
McNamee, Paul
77afd18f-a2f7-4165-8b26-de11124102ee
Keeley, Philip
15f0a3af-8d97-4efa-90a2-c53f5d56eeb3
Artus, Majid
cdfc2742-beef-4849-8d44-319bd6338da1
McBeth, John
98012716-66ba-480b-9e43-ac53b51dce61
Hannaford, Philip
b3b54676-6dd4-4367-bc2d-684ab6ac9709
Jones, Gareth T.
d3a29bae-af6f-4ea8-aebb-1004c31112a0
Basu, Neil
a7cb81d4-9e2c-4ce4-a6f4-3b2a6d5808de
Norrie, John
d648d104-39a0-481f-af0f-9a7209d50fb5
Lovell, Karina
32288970-1a2d-4abd-acd6-00e16e22ca1d
Macfarlane, Gary J., Beasley, Marcus, Prescott, Gordon, McNamee, Paul, Keeley, Philip, Artus, Majid, McBeth, John, Hannaford, Philip, Jones, Gareth T., Basu, Neil, Norrie, John and Lovell, Karina
(2016)
The maintaining musculoskeletal health (MAmMOTH) study: protocol for a randomised trial of cognitive behavioural therapy versus usual care for the prevention of chronic widespread pain.
BMC Musculoskeletal Disorders, 17, [179].
(doi:10.1186/s12891-016-1037-4).
Abstract
Background: cognitive behavioural therapy (CBT) has been shown to improve outcomes for patients with fibromyalgia, and its cardinal feature chronic widespread pain (CWP). Prediction models have now been developed which identify groups who are at high-risk of developing CWP. It would be beneficial to be able to prevent the development of CWP in these people because of the high cost of symptoms and because once established they are difficult to manage. We will test the hypothesis that among patients who are identified as at high-risk, a short course of telephone-delivered CBT (tCBT) reduces the onset of CWP. We will further determine the cost-effectiveness of such a preventative intervention.
Methods: the study will be a two-arm randomised trial testing a course of tCBT against usual care for prevention of CWP. Eligible participants will be identified from a screening questionnaire sent to patients registered at general practices within three Scottish health boards. Those returning questionnaires indicating they have visited their doctor for regional pain in the last 6 months, and who have two of, sleep problems, maladaptive behaviour response to illness, or high number of somatic symptoms, will be invited to participate. After giving consent, participants will be randomly allocated to either tCBT or usual care. We aim to recruit 473 participants to each treatment arm. Participants in the tCBT group will have an initial assessment with a CBT therapist by telephone, then 6 weekly sessions, and booster sessions 3 and 6 months after treatment start. Those in the usual care group will receive no additional intervention. Follow-up questionnaires measuring the same items as the screening survey questionnaire will be sent 3, 12 and 24 months after start of treatment. The main outcome will be CWP at the 12 month questionnaire.
Discussion: this will be the first trial of an intervention aimed at preventing fibromyalgia or CWP. The results of the study will help to inform future treatments for the prevention of chronic pain, and aetiological models of its development.
Trial registration: ClinicalTrials.gov ID: NCT02668003URL: Please check that the following URLs are working. If not, please provide alternatives: NCT02668003Alternative is: https://www.clinicaltrials.gov/ct2/show/NCT02668003>. Date registered: 28-Jan-2016.
Text
s12891-016-1037-4
- Version of Record
More information
Accepted/In Press date: 15 April 2016
Published date: 26 April 2016
Identifiers
Local EPrints ID: 491440
URI: http://eprints.soton.ac.uk/id/eprint/491440
ISSN: 1471-2474
PURE UUID: 53d3b152-37b9-4158-ae23-07b1ca315456
Catalogue record
Date deposited: 24 Jun 2024 16:45
Last modified: 25 Jun 2024 02:10
Export record
Altmetrics
Contributors
Author:
Gary J. Macfarlane
Author:
Marcus Beasley
Author:
Gordon Prescott
Author:
Paul McNamee
Author:
Philip Keeley
Author:
Majid Artus
Author:
John McBeth
Author:
Philip Hannaford
Author:
Gareth T. Jones
Author:
Neil Basu
Author:
John Norrie
Author:
Karina Lovell
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics